Introduction
Methylmalonic acidemia (MMA, MIM #251000) is an inborn error of metabolism that is biochemically characterized by accumulation of methylmalonate in urine and other body fluids [1, 2] . MMA can be caused by a defect either in the activity of the methylmalonyl-CoA mutase (MCM, MIM#51000), which catalyzes the reversible isomerization of L-methylmalonyl-CoA to succinyl-CoA, or in the synthesis of its cofactor, 5-deoxyadenosyl-cobalamin (cblA, cblB, cblC, cblD variant-2 complementation groups coded by MMAA, MMAB, MMACHC and MMADHC) [1, 3] . The deficiencies of MCM are further subdivided into mut 0 , which MMA and cardiomyopathy, and review the relevant literature.
Case
A 3-day-old, female newborn presented vomiting and lethargy. The patient was born to healthy, non-consanguineous Korean parents as their first baby at 40 weeks of gestation. Pregnancy was uneventful and she was delivered spontaneously with a birth weight of 3,090 g (25th-50th percentile). Head circumference was 38 cm (>97th percentile) and height was 53 cm (75th-90th percentile). At 3 days of age, she was transferred to our hospital. With deterioration of self-respiration, she underwent ventilator care. Initial investigations showed she had a total leukocyte count of 3,400/mm 3 Having completely recovered from the acute metabolic crisis, the patient was released at 2 weeks age with a low protein diet and medications including sodium benzoate (450 mg/kg/day), phenylbutyrate (450 mg/kg/ day) and L-carnitine (100 mg/kg/day). After discharge, she did not experience any further attacks. However, she was unexpectedly found cardiopulmonary arrest at 4 months of age without any signs of illness or metabolic crisis. Echocardiography was performed at the emergency room and revealed dilated, hypokinetic cardiac chambers, indicating cardiomyopathy. Chest radiography showed cardiomegaly with CT ratio of 0.56, which was suspected cardiomyopathy (Fig. 1B) . Because of the patient's condition, laboratory evaluation could not be performed. Seven days before the event, ammonia level was 95 mmol/L on routine check-up. Despite aggressive resuscitation, her condition deteriorated rapidly, and she died in a day. Genomic DNA was extracted from the family trio. Direct sequencing of all the coding exons, including flanking introns of MUT, was performed. Informed consent was obtained from the parents of the patient. Sequence analysis of the MUT gene revealed a G→A transition mutation at MUT cDNA nucleotide position 323 (p.Arg108His) in exon 1, which has already been reported. The other mutation, a 2-bp small deletion mutation in exon 4 (c.1033_1034del), caused a frameshift starting at codon 345, leading to a premature stop codon, which has never been reported ( Fig. 2A) . The former mutation was derived from the A B On the day of cardiopulmonary arrest, chest radiograph demonstrates cardiomegaly with cardiothoracic ratio of 0.56 and pulmonary infiltrates on both lung fields, which were thought to be secondary changes due to resuscitation.
father, and the latter mutation was derived from the mother (Fig.  2B ).
Discussion
The described case was diagnosed as early-onset MMA exhibiting a mut 0 phenotype based on clinical manifestations, and biochemical and genetic analysis. Initially, the patient had an increased C3/C2 concentration ratio of 0.49, as revealed by tandem MS/MS analysis, and an elevated ammonia level of 537 mmol/L, which is suggestive of MMA. It is very important to identify affected neonates immediately, when there are abnormal laboratory results regarding MMA in newborn screening. Cheng et al. [8] reported that referred newborns with elevated plasma C3/C2 ratios >0.4, and ammonia levels >200 mmol/L, should be highly suspected of having MMA. Unfortunately, we could not check the patient's enzyme activity owing to technical limitations. Therefore, we performed the MUT genetic analysis. Ultimately, we identified a compound heterozygous missense mutation, c.323G>A (p.Arg108His), in exon [9, 10] . The p.Arg108His mutation is relatively common in Korean patients [10] , which causes severe metabolic crisis or developmental delay. The p.Gly94Glu mutation was only found in Korean patients with MMA [9] . The p.Arg369His mutation was identified in Korean patients with MMA, Japanese patients with MMA, and an American patient with MMA [9,13,14]. The p.Leu494* mutation was found in compound heterozygous Japanese and Korean patients with MMA [10, 15] . The p.Glu117* has been found with a high prevalence in Japanese and Korean patients with MMA [16, 17] . A novel p.Leu345Serfs*15 mutation identified in the coding region in the present study occurs within the β/α barrel domain and may produce a truncated polypeptide that contains only the barrel domain and thus yield an inactive protein. Structural analyses of the mutated protein showed missing amino acids in the truncated protein (Fig. 3 ) and revealed major changes in its tertiary structure due to the deleted region (THR359-VAL750) and cutting C-terminus that will affect the cofactor 5-deoxyadenosyl-cobalamin-binding site, which causes the protein to be dysfunctional. It seems that the vast alteration in the structure of the protein causes great impacts on its function owing to its strong correlation with the protein tertiary structure. A few report of cardiac disease in MMA patients have been found in the literature. To date, seven patients (2 Caucasian, 1 Moroccan and 4 Japanese) with MMA and cardiomyopathy have been reported, and 4 of them died because of cardiomyopathy [6, 7] . And one Arab patient with MMA was reported to have been treated for heart failure due to suspected carnitine deficiency [18] . Our patient was supplemented with adequate dose of L-carnitine and presented good metabolic control, but ultimately died from cardiomyopathy. The pathogenesis of cardiomyopathy in our case remains unclear. The patient did not show any infection signs such as fever and grunting. However, de Keyzer et al. [19] suggested mitochondrial oxidative phosphorylation impairment as an additional mechanism to intoxication causes energetic-dependent cardiomyopathy in patients with MMA. Therefore, physicians should consider the potential of cardiac complication in these patients with MMA.
In summary, this is the first case with MMA and cardiomyopathy in Korea that was confirmed by genetic analysis to involve a novel MUT gene mutation. Further studies are required to understand the functional changes of proteins involved in this disorder and their associations with the phenotypic spectrum. 
